Velcade: Cancer Therapy
VELCADE® is the first oncology drug marketed and promoted by Millennium. The rapid clinical development of VELCADE-with FDA approval granted little more than four and a half years after initiation of the first clinical trial-reflects our intense commitment to novel treatments for cancer patients. To discover and develop such treatments, we focus on understanding key molecular pathways that play crucial roles in underlying disease processes, and on identifying therapeutically significant differences that may exist between people.
Embed code for Blogs
Simply copy and paste the following HTML code below into your blog, website, or MySpace profile.
Copy to Clipboard
Share this video:
Simply click the button below and select your social bookmarking site.
Tag Cloud
Category: Health & Care
VELCADE® is the first oncology drug marketed and promoted by Millennium. The rapid clinical development of VELCADE-with FDA approval granted little more than four and a half years after initiation of the first clinical...
Tags:
myeloma, drugs, treatment, patients, mcl, mantle cell lymphoma, fda, velcade, therapy, cancer, health
Views: 11542















Belize's marine life
UNAIDS: Michael Ballack PSA
IBM Release of Blade Center
UNICEF: Grasping empowerment out of uniform
UNICEF - India Kids no born registration
UNICEF - Ivory coast child soldiers
Volvo: Nutrition at the Volvo Ocean Race
Year-end Watchdog Report - Brand name drug prices continue to rise
U.S. Department of Transportation: Karaoke
Rotary International - Peace Spanish
Autism Awareness - Golf
Beauty shots of seals, archive footage 2
Fair Housing Law: Accents
Freedom From Smoking® Online Program III
UNICEF: Trading guns for textbooks
Mayor of Toronto David Miller on his city's goal for climate change
UNICEF Yemen Children face the future Nutrition
World Food Program: Colin Farrel